Lynda Charters

Trial shows treatment has acceptable safety profile, may improve visual function.

MIGS drainage device offers hope for challenging cases.

Much of today’s surgical refuse is due to the single use of virtually everything.

In an observational study, investigators are looking at the role of antibody secreting plasmablasts and GC B cells induced by the COVID-19 vaccines.

Exploring subtleties helps ophthalmologists understand postop surprises, drug reactions.

MedShr Insights has developed an early warning system that applies natural language processing, artificial intelligence, and machine learnings.

Investigators find little difference between the options.

AAO develops task forces to evaluate academy, review outcomes in ophthalmology.

Postop management with long-term topical antibiotics is critical to successful device retention.

Visible-light optical coherence tomography proves valuable in studies.

The American Medical Association is advocating equitable resource distribution of vaccinations to assist low-income countries.

According to investigators, infants may have an edge over adults, with babies demonstrating a stronger immune response to the SARS-CoV-2 virus.

Investigators find approach improved vision and visual fields in some patients.

Physicians are finding a wealth of information that is readily available.

Physicians are left to determine which treatments can offer patients best outcomes.

Amid pandemic, physicians and patients have embraced technology.

Update reduces complications

RGX-314 eyed by investigators as a therapeutic option for exudative AMD.

Option could prove to enhance safety for both patients and staff.

Use of such procedures increased markedly in analysis of IRIS Registry Data.

UK physician notes a full systemic work-up needed to determine source of infection.

Study results show that aflibercept-treated eyes are protected.

Study results show the device offers an effective long-term option for patients.

Virtual reality, home visual field testing offer new options for physicians.

ADVM-022 offers sharp decrease in treatment burden for patients with nAMD.

Technologies offer different approaches to different scenarios.

Intermediate/near vision improvements are achieved without compromising distance vision.

Investigators determine that patient rates of adherence with gonioscopy are low.

Patients frequently require a multidisciplinary approach.

A recent study may indicate the need for future research to assess the relationship between pain and the anterior chamber depth.